Successful treatment of aggressive metastatic sebaceous carcinoma with pembrolizumab

Eur J Dermatol. 2024 Jun 1;34(3):308-310. doi: 10.1684/ejd.2024.4697.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adenocarcinoma, Sebaceous / drug therapy
  • Adenocarcinoma, Sebaceous / pathology
  • Adenocarcinoma, Sebaceous / secondary
  • Aged
  • Antibodies, Monoclonal, Humanized* / therapeutic use
  • Antineoplastic Agents, Immunological* / therapeutic use
  • Female
  • Humans
  • Male
  • Sebaceous Gland Neoplasms* / drug therapy
  • Sebaceous Gland Neoplasms* / pathology

Substances

  • pembrolizumab
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents, Immunological